rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Subject Expert Committee Of The Drugs Controller General Of India

Rediff.com  »  News  »   Subject Expert Committee Of The Drugs Controller General Of India

  News for Subject Expert Committee Of The Drugs Controller General Of India

  • News
  • Business
  • Sports

DCGI approves market authorisation for Covovax as Covid booster dose

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Expert panel bats for Covovax as Covid booster jab for adults

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's COVID vaccine Covovax as a heterologous booster dose for adults who have......

Govt denies pressuring Covaxin makers for early release of vaccine

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......

Biological E's Corbevax cleared as Covid booster dose

Biological E Limited on Saturday announced that its COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous booster dose. A press release from the......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Glenmark's favipiravir under fire for 'misguided' claims of Covid-19 drug

The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective......

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Some of the well-known medicines on which the ban on sale has been lifted include Pfizer's Corex cough syrup, Glaxo's Piriton expectorant, P&G's Vicks Action 500 extra, Reckitt's D'Cold and......

It's a tough road ahead for pharma companies

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny. These companies need to ensure that not only their own quality and standards improve but also......

Gaps in clinical trial data delay compensation

Despite clinical trials coming under scrutiny, nothing much has changed on ground as many irregularities continue to exist.While the office of the Drugs Controller General of India is still......

Surprise dope testing for CWG athletes: organisers

In its bid to make the Commonwealth Games a dope-free event, the organisers on Tuesday said participating athletes will be subjected to surprise dope testing to deter them from taking banned drugs.......

Top Coverage News


World Test Championship 2023

India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

Here are news, updates and coverage from violence hit Manipur.

IPL 2023

Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z